Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
09939 KINTOR PHARMA-B
RT Nominal up1.805 +0.110 (+6.490%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others141,426-4.631%148,293164,645184,366240,250
Land & other Lease Assets9,114-6.331%9,7309,58937,47742,227
Intangible Assets95,761-10.717%107,255148,949148,940235,648
Interests in Asso. & JCEs20,28524.823%16,25116,56817,99717,945
Other Non-current Assets4,0590.720%4,0303,6457,89511,197

270,645-5.223%285,559343,396396,675547,267
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories11,008-8.965%12,0922,2150603,503
Trade Receivables2,8622.361%2,796000
Cash & Bank Balances31,297-4.399%32,737147,419445,499865,081
Other Current Assets3,127-58.990%7,62522,09627,05839,285
Assets Held for Sale0--0000

48,294-12.590%55,250171,730472,5571,507,869
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables31,853-0.841%32,12340,95681,601180,401
S-T Debt & Leases133,52855.972%85,610113,009118,230103,335
Other Current Liabilities17,54578.176%9,84712,71424,89934,391
Liab asso w/ Assets Held for Sale0--0000

182,92643.381%127,580166,679224,730318,127
Net Current Assets(134,632)86.136%(72,330)5,051247,8271,189,742
Total Assets Less Current Liabilities136,013-36.213%213,229348,447644,5021,737,009
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases55-94.433%98820,000135,690183,051
Other Non-current Liabilities26,734-9.820%29,64534,36750,70058,770

26,789-12.549%30,63354,367186,390241,821
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital3510.000%351315315315
  Reserves108,873-40.260%182,245293,765457,7971,494,873
  Others0--0000
Shareholders' Funds109,224-40.183%182,596294,080458,1121,495,188
Non-controlling Interests0--0000
Others0--0000

109,224-40.183%182,596294,080458,1121,495,188
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments------77544,62847,254
Contingent Liabilities------000
Remarks:  Real time quote last updated: 21/08/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -75,782
%Change-8.990%
EPS / (LPS)RMB -0.150
NBV Per Share (¥)RMB 0.219
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.